Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Endothelial dysfunction in hypertension.

S Taddei1, A Virdis, L Ghiadoni

  • 1Department of Internal Medicine, University of Pisa, Italy. s.taddei@int.med.unipi.it

Journal of Cardiovascular Pharmacology
|January 29, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The use of bone-modifying agents in early breast cancer: AIOM Guidelines update and perspectives.

Tumori·2025
Same author

PREDICTIVE BRCA GENETIC TESTING IN ITALIAN PATIENTS WITH BREAST CANCER: A POSITION PAPER OF ITALIAN SCIENTIFIC SOCIETIES [Italian Association of Medical Oncology(AIOM); Italian Association of Radiotherapy and Clinical Oncology (AIRO); Italian National Association of Breast Surgeons (ANISC); Italian Society of Pathological Anatomy and Diagnostic Cytology (SIAPeC-IAP); Italian Society of Surgical Oncology (SICO); Italian Society of Human Genetic (SIGU); Italian Society of General Practice (SIMG); Italian Society of Medical and Interventional Radiology (SIRM)].

Cancer treatment reviews·2025
Same author

ANN uncertainty estimates in assessing fatty liver content from ultrasound data.

Computational and structural biotechnology journal·2024
Same author

The Role of the Central Autonomic Nervous System and Psychosocial Factors in Microvascular Angina and Takotsubo Syndrome.

European cardiology·2020
Same author

Hyperuricemia and Risk of Cardiovascular Outcomes: The Experience of the URRAH (Uric Acid Right for Heart Health) Project.

High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension·2020
Same author

THE role of metabolic syndrome in blood pressure control and pulse wave velocity progression over a 3.5 years in treated hypertensive PATIENTS.

European journal of internal medicine·2020
Same journal

SGLT2 Inhibitors and Progression of Chronic Kidney Disease in Patients with Elevated Lipoprotein(a): A Real-World Cohort Study.

Journal of cardiovascular pharmacology·2026
Same journal

Aspirin in primary prevention: a case for selective use.

Journal of cardiovascular pharmacology·2026
Same journal

GLP-1 Gene Therapy Trial for Obesity and Type 2 Diabetes: Towards a New Paradigm for Chronic Disease Treatment.

Journal of cardiovascular pharmacology·2026
Same journal

Expert Opinion: Restrictions, Precautions, or Normalcy? Defining Everyday Risk in Patients Treated With IL-1 Blockers for Recurrent Pericarditis.

Journal of cardiovascular pharmacology·2026
Same journal

The Therapeutic Role of Exercise in Diabetic Cardiomyopathy: Underlying Mechanisms and Interactions with Antidiabetic Medications.

Journal of cardiovascular pharmacology·2026
Same journal

Cardiovascular Adverse Events Associated with Immune Checkpoint Inhibitors from the Perspective of Gut Microecology: Potential Roles and Research Advances of the Gut Microbiota.

Journal of cardiovascular pharmacology·2026
See all related articles

Endothelial dysfunction in hypertension impairs nitric oxide (NO) availability, promoting atherosclerosis and thrombosis. This dysfunction involves oxidative stress and altered compensatory pathways, increasing cardiovascular event risk.

Area of Science:

  • Vascular Biology
  • Cardiovascular Physiology
  • Endocrinology

Background:

  • The endothelium regulates vascular tone and protects against atherosclerosis.
  • Nitric oxide (NO) is a key endothelium-derived factor with vasodilatory and anti-atherosclerotic properties.
  • Endothelial dysfunction is a hallmark of human hypertension.

Purpose of the Study:

  • To elucidate the mechanisms of endothelial alteration in essential hypertension.
  • To investigate the role of impaired nitric oxide (NO) availability in hypertension-related cardiovascular pathology.
  • To explore the interplay between hypertension, hyperhomocysteinaemia, and endothelial function.

Main Methods:

  • Analysis of endothelial function in human hypertension.
  • Investigation of the cyclooxygenase pathway's role in NO reduction.

Related Experiment Videos

  • Assessment of compensatory pathways and endothelin-1 activity in endothelial dysfunction.

    • Main Results:

    • Essential hypertension is associated with reduced NO availability due to oxidative stress and cyclooxygenase activation.
    • A compensatory hyperpolarizing factor pathway is impaired in hypertension and further depressed by hyperhomocysteinaemia.
    • Reduced NO availability enhances endothelin-1 activity, removing a protective mechanism against vasoconstriction.

    Conclusions:

    • Impaired NO bioavailability is a critical mechanism driving endothelial dysfunction in essential hypertension.
    • Dysfunctional endothelium promotes atherosclerosis and thrombosis, increasing cardiovascular event risk.
    • The interplay of NO deficiency, oxidative stress, and altered signaling pathways contributes to cardiovascular pathology in hypertensive patients.